Diversity-Oriented Synthesis of Cyclic Azapeptides by A3 -Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Diversity-Oriented Synthesis of Cyclic Azapeptides by A3 -Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics.
- Published In:
- Angewandte Chemie (International ed. in English), 56(22), 6284-6288 (2017)
- Authors:
- Zhang, Jinqiang, Mulumba, Mukandila, Ong, Huy, Lubell, William D
- Database ID:
- RPEP-03545
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-03545APA
Zhang, Jinqiang; Mulumba, Mukandila; Ong, Huy; Lubell, William D. (2017). Diversity-Oriented Synthesis of Cyclic Azapeptides by A3 -Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics.. Angewandte Chemie (International ed. in English), 56(22), 6284-6288. https://doi.org/10.1002/anie.201611685
MLA
Zhang, Jinqiang, et al. "Diversity-Oriented Synthesis of Cyclic Azapeptides by A3 -Macrocyclization Provides High-Affinity CD36-Modulating Peptidomimetics.." Angewandte Chemie (International ed. in English), 2017. https://doi.org/10.1002/anie.201611685
RethinkPeptides
RethinkPeptides Research Database. "Diversity-Oriented Synthesis of Cyclic Azapeptides by A3 -Ma..." RPEP-03545. Retrieved from https://rethinkpeptides.com/research/zhang-2017-diversityoriented-synthesis-of-cyclic
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.